What we do
About us
News & events
Investors
Careers
What we do
About us
News & events
Investors
Overview
Press releases
Events & presentations
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Rights Issue and Directed Issue 2023
Careers
Back
Back
Mendus publishes preclinical data demonstrating synergies of ilixadencel and 4-1BB-targeting immunotherapies
8:00:00 AM
Keep reading
Mendus AB (publ) Interim Report January – June 2023
Read